Literature DB >> 6275357

Sequences at the capped 5'-ends of polyoma virus late region mRNAs: an example of extreme terminal heterogeneity.

A Cowie, C Tyndall, R Kamen.   

Abstract

We have localized with respect to the genomic DNA sequence the capped 5'-termini of polyoma virus late region mRNAs. A minimum of fifteen different purine termini were found within a 94 base pair region (66.36 to 68.12 map units, nt 5075-5168) immediately preceding the sequence determining the late region mRNA leader repeat (1-3). The most common termini occur at nearly every possible purine within a 25 bp sequence proximal to the leader repeat unit. These do not bear the usual positional relationship to a sequence resembling the 'TATA' box consensus. Deletion mutants lacking minor cap sites and sequences upstream from the principal cap sites were viable. A deletion mutant lacking one of the principal cap sites formed small plaques, while a slightly larger deletion further impinging on the principal cap site region was non-viable. The principal cap sites, which we assume to be transcriptional initiation points, are included in a DNaseI hypersensitive region of polyoma virus chromatin (4).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275357      PMCID: PMC327605          DOI: 10.1093/nar/9.23.6305

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  44 in total

1.  CELL-TRANSFORMING ABILITY OF A TEMPERATURE-SENSITIVE MUTANT OF POLYOMA VIRUS.

Authors:  M FRIED
Journal:  Proc Natl Acad Sci U S A       Date:  1965-03       Impact factor: 11.205

2.  Characterization of the mRNA's for the polyoma virus capsid proteins VP1, VP2, and VP3.

Authors:  T Hunter; W Gibson
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

3.  Polyoma virus giant RNAs contain tandem repeats of the nucleotide sequence of the entire viral genome.

Authors:  N H Acheson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

4.  Analysis of polyoma virus nuclear RNA by mini-blot hybridization.

Authors:  F Birg; J Favaloro; R Kamen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

5.  The genome of simian virus 40.

Authors:  V B Reddy; B Thimmappaya; R Dhar; K N Subramanian; B S Zain; J Pan; P K Ghosh; M L Celma; S M Weissman
Journal:  Science       Date:  1978-05-05       Impact factor: 47.728

6.  Complete nucleotide sequence of SV40 DNA.

Authors:  W Fiers; R Contreras; G Haegemann; R Rogiers; A Van de Voorde; H Van Heuverswyn; J Van Herreweghe; G Volckaert; M Ysebaert
Journal:  Nature       Date:  1978-05-11       Impact factor: 49.962

7.  Extracellular nucleases of pseudomonas BAL 31. III. Use of the double-strand deoxyriboexonuclease activity as the basis of a convenient method for the mapping of fragments of DNA produced by cleavage with restriction enzymes.

Authors:  R J Legerski; J L Hodnett; H B Gray
Journal:  Nucleic Acids Res       Date:  1978-05       Impact factor: 16.971

8.  Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran.

Authors:  J H McCutchan; J S Pagano
Journal:  J Natl Cancer Inst       Date:  1968-08       Impact factor: 13.506

9.  Mapping adenines, guanines, and pyrimidines in RNA.

Authors:  H Donis-Keller; A M Maxam; W Gilbert
Journal:  Nucleic Acids Res       Date:  1977-08       Impact factor: 16.971

10.  Transcription of the polyoma virus genome: synthesis and cleavage of giant late polyoma-specific RNA.

Authors:  N H Acheson; E Buetti; K Scherrer; R Weil
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

View more
  48 in total

1.  Biological activities of oligonucleotides spanning the F9 point mutation within the enhancer region of polyomavirus DNA.

Authors:  M Satake; K Furukawa; Y Ito
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Replication dependent and cell specific activation of the polyomavirus early promoter.

Authors:  K K Yoshimoto; L P Villarreal
Journal:  Nucleic Acids Res       Date:  1991-12       Impact factor: 16.971

3.  PEA1 and PEA3 enhancer elements are primary components of the polyomavirus late transcription initiator element.

Authors:  W Yoo; M E Martin; W R Folk
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

4.  Characterization of an unique RNA initiated immediately upstream from human alpha 1 globin gene in vivo and in vitro: polymerase II-dependence, tissue specificity, and subcellular location.

Authors:  J Hess; C Perez-Stable; A Deisseroth; C K Shen
Journal:  Nucleic Acids Res       Date:  1985-09-11       Impact factor: 16.971

5.  Correlation between patterns of DNase I-hypersensitive sites and upstream promoter activity of the human epsilon-globin gene at different stages of erythroid development.

Authors:  P Bushel; K Rego; L Mendelsohn; M Allan
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

6.  Replication-dependent transactivation of the polyomavirus late promoter.

Authors:  K B Cahill; A J Roome; G G Carmichael
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

7.  Characterization of two novel YY1 binding sites in the polyomavirus late promoter.

Authors:  F Martelli; C Iacobini; M Caruso; A Felsani
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Deletion analysis of the polyomavirus late promoter: evidence for both positive and negative elements in the absence of early proteins.

Authors:  K B Cahill; G G Carmichael
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  Control elements situated downstream of the major transcriptional start site are sufficient for highly efficient polyomavirus late transcription.

Authors:  B Bourachot; M Yaniv; P Herbomel
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

10.  Heterogeneous initiation regions for transcription of the chicken ovomucoid gene.

Authors:  E C Lai; D R Roop; M J Tsai; S L Woo; B W O'Malley
Journal:  Nucleic Acids Res       Date:  1982-09-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.